KBKatrine Berg

Katrine Berg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katrine Berg has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Myocardial External Efficiency and Energetic Adaptation After Heart Transplantation: An Exploratory Study

    by Katrine Berg Okholm, Mette Louise Gram Kjærulff, Kristoffer Berg Hansen, Tor Skibsted Clemmensen, Steen Hvitfeldt Poulsen, Lars Poulsen Tolbod, Lars Christian Gormsen, Henrik Wiggers, Hans Erik Bøtker, Bent Roni Ranghøj Nielsen, et al.

    Background.: Mitochondrial dysfunction and impaired myocardial energetics may contribute to graft dysfunction after heart transplantation (HTX). We aimed to characterize early posttransplant myocardial external efficiency (MEE) and its relationship with mitochondrial capacity. Methods.: In this prospective single-center study, 22 HTX recipients underwent [ 11 C]acetate positron emission tomography, echocardiography, biomarker testing, and high-resolution respirometry of endomyocardial biopsies once between week 1 and 3 and at 6 mo post-HTX. Temporal changes in positron emission tomography–derived MEE, cardiac output, and myocardial oxygen consumption were evaluated within patients and compared with those of 20 control participants. Mitochondrial capacity was assessed only in HTX recipients. Results.: MEE increased from 18 ± 5% to 21 ± 5% at 6 mo post-HTX ( P = 0.003) but remained lower than in control participants (26 ± 6%, P < 0.0001). Cardiac output, myocardial oxygen consumption, and mitochondrial oxidative capacity did not change significantly over time. At 6 mo, both MEE and mitochondrial oxidative capacity correlated with left-ventricular global longitudinal strain ( r = –0.49, P = 0.002; r = –0.58, P = 0.010, respectively). Furthermore, MEE was inversely associated with troponin I ( r = –0.49, P = 0.030) and N-terminal pro-brain natriuretic peptide ( r  = –0.35, P = 0.029). Conclusions.: MEE improved significantly from 1–3 wk to 6 mo after HTX. Both MEE and mitochondrial respiratory function were associated with left-ventricular contractile performance. Overall, these findings suggest alterations in myocardial energetics during early graft recovery and support a link between oxidative metabolism and graft performance.

  • Mitochondrial Function After Normothermic Regional Perfusion or Direct Procurement Followed by Hypothermic Oxygenated Machine Perfusion in Heart Transplantation After Circulatory Death

    by Katrine Berg, Imran Bsc Ertugrul, Jacob M. Seefeldt, Nichlas R. Jespersen, Frederik F. Dalsgaard, Pia K. Ryhammer, Michael Pedersen, Lars Bo Ilkjaer, Michiel Hu, Michiel E. Erasmus, et al.

    Background.: Strategies to minimize ischemic damage during heart transplantation (HTX) by donation after circulatory death (DCD) are warranted because the inevitable ischemic injury linked to DCD HTX deteriorates mitochondrial respiratory capacity and ultimately graft quality. This study aimed to examine the myocardial mitochondrial function during DCD HTX with hypothermic oxygenated machine perfusion (HOPE) and compare the effect of normothermic regional perfusion (NRP) with that of direct procurement and perfusion (DPP). Methods.: A porcine DCD HTX model was used with hearts subjected to either DPP (n = 6) or NRP (n = 7) followed by HOPE and orthotopic HTX. Mitochondrial respiratory function was analyzed by high-resolution respirometry in left ventricle biopsies at baseline, after 180 min of HOPE, and after 60 min of reperfusion post-HTX. Results.: Mitochondrial oxidative phosphorylation (P = 0.0008), respiratory control ratio (P = 0.04), and coupling efficiency (P = 0.04) declined during DCD HTX. Fatty acid oxidation was preserved after 3 h of HOPE with a modest, statistically nonsignificant decline after reperfusion (P = 0.2). Oxidative phosphorylation was inversely correlated with troponin-T levels (r = –0.70, P = 0.0004). No statistically significant difference in mitochondrial respiratory capacity was observed between participants exposed to NRP and DPP. Conclusions.: Mitochondrial respiratory capacity declined gradually throughout the course of DCD HTX and correlated with the degree of myocardial damage. Following HOPE, the extent of mitochondrial deterioration was comparable between NRP and DPP.


  • Open Access

    Effects of ketone body 3-hydroxybutyrate on cardiac and mitochondrial function during donation after circulatory death heart transplantation

    by Jacob Marthinsen Seefeldt, Yaara Libai, Katrine Berg, Nichlas Riise Jespersen, Thomas Ravn Lassen, Frederik Flyvholm Dalsgaard, Pia Ryhammer, Michael Pedersen, Lars Bo Ilkjaer, Michiel A. Hu, et al.

    Normothermic regional perfusion (NRP) allows assessment of therapeutic interventions prior to donation after circulatory death transplantation. Sodium-3-hydroxybutyrate (3-OHB) increases cardiac output in heart failure patients and diminishes ischemia–reperfusion injury, presumably by improving mitochondrial metabolism. We investigated effects of 3-OHB on cardiac and mitochondrial function in transplanted hearts and in cardiac organoids. Donor pigs (n = 14) underwent circulatory death followed by NRP. Following static cold storage, hearts were transplanted into recipient pigs. 3-OHB or Ringer’s acetate infusions were initiated during NRP and after transplantation. We evaluated hemodynamics and mitochondrial function. 3-OHB mediated effects on contractility, relaxation, calcium, and conduction were tested in cardiac organoids from human pluripotent stem cells. Following NRP, 3-OHB increased cardiac output (P < 0.0001) by increasing stroke volume (P = 0.006), dP/dt (P = 0.02) and reducing arterial elastance (P = 0.02). Following transplantation, infusion of 3-OHB maintained mitochondrial respiration (P = 0.009) but caused inotropy-resistant vasoplegia that prevented weaning. In cardiac organoids, 3-OHB increased contraction amplitude (P = 0.002) and shortened contraction duration (P = 0.013) without affecting calcium handling or conduction velocity. 3-OHB had beneficial cardiac effects and may have a potential to secure cardiac function during heart transplantation. Further studies are needed to optimize administration practice in donors and recipients and to validate the effect on mitochondrial function.


  • Abnormal mitochondrial function and morphology in heart transplanted patients with cardiac allograft vasculopathy

    by Emil Dariush Lichscheidt, Nichlas Riise Jespersen, Bent Roni Ranghøj Nielsen, Katrine Berg, Jacob Seefeldt, Jens Randel Nyengaard, Hans Erik Bøtker, Hans Eiskjær


  • Burden of arrhythmia and silent ischemia in heart transplant patients with cardiac allograft vasculopathy

    by Katrine Berg, Kamillla Pernille Bjerre, Tor Skibsted Clemmensen, Brian Bridal Løgstrup, Henning Mølgaard, Steen Hvitfeldt Poulsen, Hans Eiskjær

    The incidence of sudden cardiac death (SCD) following heart transplantation (HTx) accounts for approximately 10% of post-HTx deaths. Ischemia, brady- and tachy-arrhythmias caused by rejection and cardiac allograft vasculopathy (CAV) seem related to SCD. Hence, we aimed to investigate the relation between CAV, arrhythmias and silent ischemia in long-term HTx patients. Methods. 49 HTx patients were included. Patients were CAV classified in accordance with guidelines from the International Society of Heart and Lung Transplantation. Patients were divided into predefined CAV groups (CAV 0, CAV 1, CAV 2 + 3). Incidences of arrhythmia and silent ischemia were detected by 48-h electrocardiogram monitoring and analyzed blinded to CAV-status. Results. Median time since transplantation was 9 years [IQR 4–14]. We observed a higher incidence of non-sustained ventricular tachycardia (NSVT) in CAV 2 + 3 patients than CAV 0 and 1 patients (p = .01). Likewise, isolated premature ventricular complexes (PVC) (p = .01) and PQ-interval prolongation (p = .01) were more frequent in CAV 2 + 3 patients than CAV 0 and 1 patients. Silent ischemia was only observed among CAV 3 patients (p = .04). We saw no significant difference in the incidence of supraventricular tachycardia among CAV groups (p = .21). Likewise, no difference in the right bundle branch block was observed (p = .68). Conclusion. NSVT was associated with CAV status in long-term HTx patients. Patients with moderate to severe CAV showed higher incidences of PVCs and PQ-interval prolongation than patients with mild or no CAV. Silent ischemia was only seen in patients with severe CAV.


  • Open Access

    Preemptive Cautions Prior to Final İntestinal Transplantation: Four Golden Criteria in Predicting the Outcome and Long-Term Survival of Short Bowel Syndrome: Is the Remaining Bowel Length is at or above 50 Cm? Can Patient Survive Over 24 Months in Spite of any Complications? Younger Age? and Lesser Accompanying Co-Morbidity?

    by Berg Katrine, Bjerre Kamillla Pernille, Clemmensen Tor Skibsted, Løgstrup Brian Bridal, Mølgaard Henning, Poulsen Steen Hvitfeldt, Eiskjær Hans

    The incidence of sudden cardiac death (SCD) following heart transplantation (HTx) accounts for approximately 20% of post HTx deaths. Ischemia, brady- and tachy-arrhythmias caused by rejection and cardiac allograft vasculopathy (CAV) seem related to SCD. Hence, we aimed to investigate the relation between CAV, arrhythmias and silent ischemia in long-termHTx patients.

  • Survival, graft function, and incidence of allograft vasculopathy in heart transplant patients receiving adverse risk profile donor hearts

    by Katrine Berg, Tor Skibsted Clemmensen, Else Marie Tram, Pernille Koefoed‐Nielsen, Lars B. Ilkjær, Steen Hvitfeldt Poulsen, Hans Eiskjær

    Aim: To clarify if use of adverse cardiovascular risk profile (ARP) grafts is associated with impaired long‐term outcomes after heart transplantation (HTx).Methods: Survival was obtained from Scandia Transplant and a local database.ARP donor inclusion criteria: ≥55 years, diabetes mellitus, arterial hypertension, hypoxemia‐induced death, impaired left ventricular (LV) ejection fraction. ARP donors were compared to donors not meeting the eligibility criteria. Sub‐analyses were made for donor age.Results: In total, 302 HTxs were performed in 296 patients from 31 December 1992 to 11 August 2016. Median survival was 16.5 years (95% CI, 14.3‐22.9), there was no difference between profiles (HR 0.63 (95% CI, 0.33‐1.19), P = 0.15). LV systolic function was significantly better in ARP donors (P < 0.05). Freedom from cardiac allograft vasculopathy (CAV) was comparable between profiles, HR 0.9 (95% CI 0.5‐1.5). Donor age predisposes to CAV (high to low age: HR 2.8 (95% CI 1.7‐4.5), P < 0.0001). Median survival was comparable in patients receiving allograft ≥55 and P = 0.38).Conclusion: Long‐term survival and graft function were excellent in patients receiving ARP grafts. Older grafts were associated with CAV but did not influence survival. Thus, the strategy of expanding availability using ARP grafts seems safe.


  • Detection of early changes in the coronary artery microstructure after heart transplantation: A prospective optical coherence tomography study

    by Tor Skibsted Clemmensen, Niels Ramsing Holm, Hans Eiskjær, Lars Jakobsen, Katrine Berg, Omeed Neghabat, Brian Bridal Løgstrup, Evald Høj Christiansen, Jouke Dijkstra, Christian Juhl Terkelsen, et al.